BioSpace News Archive

BioMidwest

Aerpio Hosting Key Opinion Leader Call on New Therapeutic Agents for COVID-19Call Taking Place on Thursday, November 12th @ 11amET

Aerpio Pharmaceuticals, Inc. announced that it will host a key opinion leader call on new therapeutic agents for the treatment of COVID-19 on Thursday, November 12, 2020 at 11am Eastern Time.

November 5, 2020
·
8 min read
Business

Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced its third quarter 2020 financial results and provided a business update.

November 5, 2020
·
9 min read
Business

Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update

Strategic focus on clinical GoCAR-T® programs with plans to initiate Phase 1/2 enrollment of BPX-601 in mCRPC and BPX-603 in HER2+ solid tumors by end of year

November 5, 2020
·
9 min read
Business

Misonix Fiscal 2021 First Quarter Revenue Rises 59% to $17.7 Million

Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, reported unaudited financial results for the fiscal 2021 first quarter ended September 30, 2020 as summarized below:

November 5, 2020
·
13 min read
Business

Assembly Biosciences Reports Third Quarter 2020 Financial Results and Business Update

Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus and diseases associated with the microbiome, reported financial results and a business update for the third quarter ended September 30, 2020.

November 5, 2020
·
10 min read
Business

Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, reported financial results for the third quarter of 2020.

November 5, 2020
·
35 min read
Biotech Beach

GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum

GenMark Diagnostics, Inc., a leading provider of automated, multiplex molecular diagnostic testing systems, announced that the company plans to participate in the upcoming Canaccord Virtual MedTech & Diagnostics Forum.

November 5, 2020
·
1 min read
Business

Adverum Biotechnologies Reports Recent Business Progress and Third Quarter 2020 Financial Results

Company to host conference call and webcast with KOLs to discuss new data from Cohorts 1-4 of OPTIC Phase 1 trial of ADVM-022 for wet AMD on November 14, 2020 at 7:30 am PT

November 5, 2020
·
11 min read
Business

Y-mAbs Announces Third Quarter 2020 Financial Results and Recent Corporate Developments

Y-mAbs Therapeutics, Inc. a development-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, reported financial results for the third quarter 2020.

November 5, 2020
·
10 min read
Business

Denali Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights

Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases, reported financial results for the third quarter ended September 30, 2020 and provided business highlights.

November 5, 2020
·
12 min read